K. Kaida

1.5k total citations
18 papers, 796 citations indexed

About

K. Kaida is a scholar working on Neurology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, K. Kaida has authored 18 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 13 papers in Cellular and Molecular Neuroscience and 2 papers in Genetics. Recurrent topics in K. Kaida's work include Peripheral Neuropathies and Disorders (14 papers), Hereditary Neurological Disorders (12 papers) and Autoimmune Neurological Disorders and Treatments (5 papers). K. Kaida is often cited by papers focused on Peripheral Neuropathies and Disorders (14 papers), Hereditary Neurological Disorders (12 papers) and Autoimmune Neurological Disorders and Treatments (5 papers). K. Kaida collaborates with scholars based in Japan, United States and United Kingdom. K. Kaida's co-authors include Susumu Kusunoki, Robert K. Yu, K. Kamakura, Takuro Ariga, K Motoyoshi, Mami Kanzaki, Ichiro Kanazawa, Daiji Morita, Ryo Yamasaki and Masato Kadoya and has published in prestigious journals such as PLoS ONE, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

K. Kaida

18 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Kaida Japan 13 620 453 95 92 71 18 796
Rabab Debs France 12 237 0.4× 115 0.3× 114 1.2× 43 0.5× 72 1.0× 25 486
José Luís Muñoz-Blanco Spain 11 568 0.9× 120 0.3× 128 1.3× 53 0.6× 26 0.4× 27 712
John E. Antoine France 10 496 0.8× 147 0.3× 92 1.0× 13 0.1× 22 0.3× 20 579
Bhim Singhal India 14 147 0.2× 92 0.2× 236 2.5× 12 0.1× 111 1.6× 21 506
Hakan Çetin Austria 16 390 0.6× 66 0.1× 147 1.5× 11 0.1× 38 0.5× 49 590
R.I. Craggs United Kingdom 12 129 0.2× 78 0.2× 67 0.7× 43 0.5× 23 0.3× 22 387
Peter Karachunski United States 15 273 0.4× 47 0.1× 281 3.0× 125 1.4× 10 0.1× 29 710
Martin Krenn Austria 13 103 0.2× 86 0.2× 135 1.4× 21 0.2× 14 0.2× 36 394
Zen Kobayashi Japan 11 284 0.5× 59 0.1× 127 1.3× 14 0.2× 27 0.4× 50 434
Paul Shillito United Kingdom 6 302 0.5× 81 0.2× 197 2.1× 13 0.1× 9 0.1× 9 446

Countries citing papers authored by K. Kaida

Since Specialization
Citations

This map shows the geographic impact of K. Kaida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Kaida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Kaida more than expected).

Fields of papers citing papers by K. Kaida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Kaida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Kaida. The network helps show where K. Kaida may publish in the future.

Co-authorship network of co-authors of K. Kaida

This figure shows the co-authorship network connecting the top 25 collaborators of K. Kaida. A scholar is included among the top collaborators of K. Kaida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Kaida. K. Kaida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yamagishi, Yuko, Motoi Kuwahara, Hidekazu Suzuki, et al.. (2020). Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome. Journal of Neurology Neurosurgery & Psychiatry. 91(12). 1339–1342. 8 indexed citations
2.
Kadoya, Masato, et al.. (2017). Rituximab therapy and clinical management in anti-NMDA receptor antibody encephalitis refractory to first-line immunotherapy: Japanese case series. Journal of the Neurological Sciences. 381. 911–911. 3 indexed citations
3.
Koike, Haruki, Masato Kadoya, K. Kaida, et al.. (2017). Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies. Journal of Neurology Neurosurgery & Psychiatry. 88(6). 465–473. 149 indexed citations
4.
Kadoya, Masato, Chiseko Ikenaga, Akatsuki Kubota, et al.. (2017). Evaluation for the clinical significance of cancer-association in anti-SRP antibody-positive myopathy. Journal of the Neurological Sciences. 381. 470–470. 1 indexed citations
5.
Nakane, Shunya, Osamu Higuchi, Michiaki Koga, et al.. (2015). Clinical Features of Autoimmune Autonomic Ganglionopathy and the Detection of Subunit-Specific Autoantibodies to the Ganglionic Acetylcholine Receptor in Japanese Patients. PLoS ONE. 10(3). e0118312–e0118312. 56 indexed citations
6.
Suzuki, Shigeaki, Atsushi Baba, K. Kaida, et al.. (2013). Cardiac involvements in myasthenia gravis associated with anti‐Kv1.4 antibodies. European Journal of Neurology. 21(2). 223–230. 58 indexed citations
7.
Yu, Robert K., Toshio Ariga, Seigo Usuki, & K. Kaida. (2011). Pathological Roles of Ganglioside Mimicry in Guillain–Barré Syndrome and Related Neuropathies. Advances in experimental medicine and biology. 705. 349–365. 12 indexed citations
8.
Kaida, K. & Susumu Kusunoki. (2011). Antiganglioside antibodies-Their pathophysiological effects on Guillain-Barre Syndrome and variants-. Japanese Journal of Clinical Immunology. 34(1). 29–39. 1 indexed citations
9.
Kaida, K., Takuro Ariga, & Robert K. Yu. (2009). Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A review. Glycobiology. 19(7). 676–692. 114 indexed citations
10.
Kanzaki, Mami, K. Kaida, Masami Ueda, et al.. (2008). Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes. Journal of Neurology Neurosurgery & Psychiatry. 79(10). 1148–1152. 50 indexed citations
11.
Kaida, K., Daiji Morita, Mami Kanzaki, et al.. (2006). Anti-ganglioside complex antibodies associated with severe disability in GBS. Journal of Neuroimmunology. 182(1-2). 212–218. 86 indexed citations
12.
Kaida, K.. (2006). Anti-ganglioside complex antibodies in Miller Fisher syndrome. Journal of Neurology Neurosurgery & Psychiatry. 77(9). 1043–1046. 76 indexed citations
13.
Ogawa, Go, Hitoshi Mochizuki, Mami Kanzaki, et al.. (2004). Seasonal variation of multiple sclerosis exacerbations in Japan. Neurological Sciences. 24(6). 417–419. 38 indexed citations
14.
Kaida, K., Susumu Kusunoki, Mami Kanzaki, et al.. (2004). Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barre syndrome. Neurology. 62(5). 821–824. 39 indexed citations
15.
Kaida, K., Susumu Kusunoki, K. Kamakura, K Motoyoshi, & Ichiro Kanazawa. (2003). GalNAc-GD1a in human peripheral nerve. Neurology. 61(4). 465–470. 47 indexed citations
16.
Miyazaki, Toru, et al.. (2001). Guillain–Barre syndrome associated with IgG monospecific to ganglioside GD1b. Neurology. 56(9). 1227–1229. 32 indexed citations
17.
Kaida, K., Susumu Kusunoki, K. Kamakura, K Motoyoshi, & Ichiro Kanazawa. (2000). GUILLAIN‐BARRE SYNDROME WITH ANTIBODY TO A GANGLIOSIDE, N‐ACETYLGALACTOSAMINYL GD1A. Journal of the Peripheral Nervous System. 5(4). 237–237. 1 indexed citations
18.
Matsuo, Hirotaka, Keiko Kamakura, Masaaki Saito, et al.. (1999). Familial Paroxysmal Dystonic Choreoathetosis. Archives of Neurology. 56(6). 721–721. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026